Prior to the financial crisis of 2008/09, it was widely believed in the stock market that certain sectors – most notably utilities, pharmaceuticals, food retailing and tobacco – were far less vulnerable to market downturns.

02 May 2018
The Monthly
Time Finance plc (TIME:LON), 36.0 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Allergy Therapeutics plc (AGY:LON), 2.4 | Alliance Pharma plc (APH:LON), 38.9 | Arbuthnot Banking Group PLC (ARBB:LON), 980 | Avacta Group PLC (AVCT:LON), 133 | Bionomics Ltd (BNO:ASX), 0 | Burford Capital Limited (BUR:LON), 1,086 | Chamberlin plc (CMH:LON), 2.6 | City of London Investment Group PLC (CLIG:LON), 316 | Diurnal Group plc (DNL:LON), 0 | Evgen Pharma Plc (EVG:LON), 1.7 | Gateley (Holdings) Plc (GTLY:LON), 164 | Genedrive Plc (GDR:LON), 10.2 | Inland Homes PLC (INL:LON), 0 | Koovs (KOOV:LON), 0 | Morses Club Plc (MCL:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 0 | Yourgene Health Plc (YGEN:LON), 0 | Primary Health Properties PLC (PHP:LON), 99.2 | R.E.A. Holdings plc (RE:LON), 72.0 | Redx Pharma Plc (REDX:LON), 23.5 | Scancell Holdings Plc (SCLP:LON), 11.8 | Surface Transforms PLC (SCE:LON), 11.6 | 600 Group PLC (SIXH:LON), 2.6 | Tissue Regenix Group plc (TRX:LON), 56.0 | Titon Holdings Plc (TON:LON), 80.0 | Oxford BioMedica plc (OXB:LON), 190 | ValiRx PLC (VAL:LON), 10.8

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly
Time Finance plc (TIME:LON), 36.0 | Abzena (ABZA:LON), 0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Allergy Therapeutics plc (AGY:LON), 2.4 | Alliance Pharma plc (APH:LON), 38.9 | Arbuthnot Banking Group PLC (ARBB:LON), 980 | Avacta Group PLC (AVCT:LON), 133 | Bionomics Ltd (BNO:ASX), 0 | Burford Capital Limited (BUR:LON), 1,086 | Chamberlin plc (CMH:LON), 2.6 | City of London Investment Group PLC (CLIG:LON), 316 | Diurnal Group plc (DNL:LON), 0 | Evgen Pharma Plc (EVG:LON), 1.7 | Gateley (Holdings) Plc (GTLY:LON), 164 | Genedrive Plc (GDR:LON), 10.2 | Inland Homes PLC (INL:LON), 0 | Koovs (KOOV:LON), 0 | Morses Club Plc (MCL:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 0 | Yourgene Health Plc (YGEN:LON), 0 | Primary Health Properties PLC (PHP:LON), 99.2 | R.E.A. Holdings plc (RE:LON), 72.0 | Redx Pharma Plc (REDX:LON), 23.5 | Scancell Holdings Plc (SCLP:LON), 11.8 | Surface Transforms PLC (SCE:LON), 11.6 | 600 Group PLC (SIXH:LON), 2.6 | Tissue Regenix Group plc (TRX:LON), 56.0 | Titon Holdings Plc (TON:LON), 80.0 | Oxford BioMedica plc (OXB:LON), 190 | ValiRx PLC (VAL:LON), 10.8
- Published:
02 May 2018 -
Author:
Mark Thomas -
Pages:
48 -
Prior to the financial crisis of 2008/09, it was widely believed in the stock market that certain sectors – most notably utilities, pharmaceuticals, food retailing and tobacco – were far less vulnerable to market downturns.